7/15/11 Contest Update
Was it the debt ceiling game of chicken that floored the market this week? Or was it Lord Voldemort? I know the answer but you’ll have to hack my phone to get it.
At Friday’s close, the Nasdaq Biotech Index was up 15.02% YTD (vs. up 17.49% YTD a week ago) and the Contest median was up 17.83% YTD (vs. up 18.70% YTD a week ago). The Nasdaq Composite Index was up 5.16% YTD (vs. up 7.80% YTD a week ago).
GENE’s portfolio (up 79.41% YTD) got another big ICGN boost and widened its lead. And two newcomers slipped into second and third place, JIBAC’s portfolio (up 55.56% YTD) and FIB’s portfolio (up 54.52% YTD). But with three other portfolios up over 50% YTD, it’s a hot race for the runner-up spot.
At Friday's close, 33 of the 38 Contest portfolios were still in the black, while 22 of the 38 were beating the NBI.
Below is the Top Ten list. Also below are the Top 5 & Bottom 5 Stocks ranked by % Gained and % Lost for the week (foreign stock prices are not converted to US$ in these two tables).
Portfolio adjustments: None
Have a terrific weekend biotechies!
(All corrections, especially adjustments for splits, greatly appreciated.)
7/15/11
Rank Name Profit/Loss
1 GENE 79,405
2 JIBAC 55,561
3 FIB 54,523
4 ROCKY 54,494
5 MCBIO 54,430
6 RRGE 51,687
7 CRAZYP 49,391
8 RKRW 48,270
9 IJF 37,601
10 BIOFISH 35,872
Week's Top 5 Gainers
Symbol 7/8 7/15 % change
ICGN 5.86 7.43 26.79%
ROSGD 1.25 1.54 23.20%
PBTH 5.07 6.10 20.32%
SKBI 3.65 4.16 13.97%
IDIX 5.40 6.08 12.59%
Week's Top 5 Losers
Symbol 7/8 7/15 % change
DCTH 6.34 5.06 -20.19%
NRGX.OB 0.65 0.55 -15.38%
MRNA 0.23 0.20 -15.37%
CBPO 10.83 9.21 -14.96%
PIP 3.04 2.67 -12.17% |
